Profile data is unavailable for this security.
About the company
BrightPath Biotherapeutics Co., Ltd. is a Japan-based company mainly engaged in the development of pharmaceutical products. The Company is a biopharmaceutical venture company focused on developing cancer immunotherapeutic. The Companies business model covers drug discovery research and early clinical development of cancer immunotherapy; conducting of early-phase clinical trials; and development, manufacturing, and launching of the drugs as commercial products in Japan and abroad. The Company also generates the revenues from license fees from the pharmaceutical companies.
- Revenue in JPY (TTM)84.00k
- Net income in JPY-1.20bn
- Incorporated2003
- Employees24.00
- LocationBrightPath Biotherapeutics Co Ltd7F, Kojimachi Central Bldg2-2-4, Koji-machiCHIYODA-KU 102-0083JapanJPN
- Phone+81 444403939
- Fax+81 942386564
- Websitehttps://www.brightpathbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PhoenixBio Co Ltd | 1.73bn | 7.40m | 1.87bn | 70.00 | 356.40 | 1.01 | 56.73 | 1.08 | 1.29 | 1.29 | 444.66 | 456.80 | 0.5927 | 1.06 | 5.86 | 24,647,240.00 | 0.2543 | -4.04 | 0.3579 | -5.28 | 72.57 | 65.88 | 0.429 | -6.97 | 3.89 | 1.52 | 0.20 | -- | -19.24 | 6.91 | -94.65 | -- | -9.96 | -- |
| D.Western Therapeutics Institute Inc | 464.18m | -1.09bn | 2.80bn | 21.00 | -- | 2.91 | -- | 6.04 | -33.74 | -33.74 | 14.43 | 25.80 | 0.19 | 0.3314 | 4.10 | 22,103,620.00 | -44.77 | -13.06 | -47.81 | -14.36 | 91.27 | 94.29 | -235.62 | -72.51 | 18.24 | -- | 0.5644 | -- | -4.40 | 7.90 | -89.07 | -- | 7.08 | -- |
| Ribomic Inc | 1.50m | -944.01m | 3.33bn | 24.00 | -- | 0.9425 | -- | 2,222.89 | -26.30 | -26.30 | 0.0418 | 87.00 | 0.0004 | -- | 0.0286 | 62,500.00 | -24.93 | -30.52 | -26.13 | -31.71 | -- | -- | -62,934.20 | -1,777.84 | 21.55 | -- | 0.00 | -- | -100.00 | -- | 38.04 | -- | 4.42 | -- |
| Human Metabolome Technologies Inc | 1.35bn | 243.25m | 3.67bn | 57.00 | 15.08 | 1.88 | 12.55 | 2.73 | 41.12 | 41.12 | 227.58 | 329.08 | 0.5499 | 15.07 | 7.52 | -- | 9.94 | 8.49 | 12.91 | 10.80 | 64.60 | 69.25 | 18.08 | 13.21 | 3.25 | -- | 0.1041 | 18.31 | 3.57 | -- | -14.88 | -- | -- | -- |
| BrightPath Biotherapeutics Co Ltd | 84.00k | -1.20bn | 4.31bn | 24.00 | -- | 5.51 | -- | 51,251.76 | -18.25 | -18.25 | 0.0013 | 9.44 | 0.00008 | -- | 3.50 | 3,500.00 | -108.84 | -51.56 | -116.51 | -54.32 | 75.00 | 68.63 | -1,431,842.00 | -22,321.82 | -- | -274.19 | 0.00 | -- | -98.64 | -78.47 | 21.37 | -- | -46.55 | -- |
| FunPep Co Ltd | 530.00k | -727.29m | 4.70bn | 15.00 | -- | 1.83 | -- | 8,867.35 | -29.40 | -29.40 | 0.0215 | 82.55 | 0.0002 | -- | -- | 35,333.33 | -26.27 | -27.10 | -29.12 | -28.75 | -- | -- | -137,223.40 | -815.82 | 5.06 | -1,004.01 | 0.00 | -- | -50.33 | -72.80 | 20.39 | -- | -13.14 | -- |
| Cyfuse Biomedical KK | 60.88m | -671.82m | 4.78bn | 21.00 | -- | 1.63 | -- | 78.54 | -84.88 | -84.88 | 7.71 | 360.49 | 0.0148 | 0.5613 | 24.17 | 2,899,143.00 | -16.32 | -- | -19.11 | -- | 58.30 | -- | -1,103.48 | -- | 6.02 | -84.25 | 0.2153 | -- | -83.68 | -- | -24.32 | -- | -- | -- |
| DNA Chip Research Inc | 629.13m | -172.44m | 5.20bn | 37.00 | -- | 7.30 | -- | 8.26 | -26.95 | -26.95 | 97.41 | 105.25 | 0.739 | 9.29 | 5.94 | 17,003,490.00 | -20.25 | -23.49 | -24.51 | -26.70 | 28.19 | 14.28 | -27.41 | -54.10 | 2.98 | -926.97 | 0.00 | -- | 49.74 | 6.33 | 31.48 | -- | -15.75 | -- |
| Kidswell Bio Corp | 2.87bn | -1.13bn | 5.24bn | 42.00 | -- | 7.12 | -- | 1.83 | -30.62 | -30.62 | 77.19 | 18.12 | 0.7495 | 1.37 | 7.46 | 68,290,810.00 | -29.48 | -57.41 | -47.94 | -81.13 | 42.46 | 55.20 | -39.33 | -123.52 | 1.45 | -22.17 | 0.7709 | -- | -12.43 | 18.93 | -116.31 | -- | -- | -- |
| Modalis Therapeutics Corp | 0.00 | -2.14bn | 5.85bn | 37.00 | -- | 3.83 | -- | -- | -64.28 | -64.28 | 0.00 | 28.21 | 0.00 | -- | -- | 0.00 | -100.32 | -29.19 | -110.17 | -30.02 | -- | -- | -- | -597.35 | 12.87 | -- | 0.1274 | -- | -100.00 | -- | 11.50 | -- | 135.50 | -- |
| Kringle Pharma Inc | 79.22m | -793.94m | 5.90bn | 13.00 | -- | 2.52 | -- | 74.52 | -134.08 | -134.08 | 13.09 | 344.17 | 0.0274 | -- | 1.66 | 6,093,462.00 | -27.49 | -19.00 | -29.10 | -20.23 | -- | -- | -1,002.26 | -156.51 | 30.96 | -- | 0.00 | -- | -82.33 | -- | -157.41 | -- | -- | -- |
| Veritas In Silico Inc | -100.00bn | -100.00bn | 6.26bn | 15.00 | -- | 2.66 | -- | -- | -- | -- | -- | 363.16 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 63.22 | -- | 0.00 | -- | 101.54 | -- | 123.38 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to BrightPath Biotherapeutics Co Ltd's reporting currency: Japanese Yen JPY
2.30%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Evolution Capital Management LLCas of 19 Aug 2024 | 1.46m | 1.77% |
| Simplex Asset Management Co., Ltd.as of 05 Sep 2024 | 403.80k | 0.49% |
| SPARX Asset Management Co., Ltd.as of 10 Mar 2023 | 33.50k | 0.04% |
Data from 28 Jun 2024 - 12 Sep 2024Source: FactSet Research Systems Inc.
